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Abstract
Background: Cell migration is a highly regulated process that involves the formation and turnover of cell-matrix contact
sites termed focal adhesions. Rho-family GTPases are molecular switches that regulate actin and focal adhesion dynamics in
cells. Guanine nucleotide exchange factors (GEFs) activate Rho-family GTPases. Rgnef (p190RhoGEF) is a ubiquitous 190 kDa
GEF implicated in the control of colon carcinoma and fibroblast cell motility.
Principal Findings: Rgnef exon 24 floxed mice (Rgnef
flox) were created and crossed with cytomegalovirus (CMV)-driven Cre
recombinase transgenic mice to inactivate Rgnef expression in all tissues during early development. Heterozygous Rgnef
WT/flox
(Cre+) crosses yielded normal Mendelian ratios at embryonic day 13.5, but Rgnef
flox/flox (Cre+) mice numbers at 3 weeks of age were
significantly less than expected. Rgnef
flox/flox (Cre+)( R g n e f 2/2) embryos and primary mouse embryo fibroblasts (MEFs) were
isolated and verified to lack Rgnef protein expression. When compared to wildtype (WT) littermate MEFs, loss of Rgnef significantly
inhibited haptotaxis migration, wound closure motility, focal adhesion number, and RhoA GTPase activation after fibronectin-
integrin stimulation. In WT MEFs, Rgnef activation occurs within 60 minutes upon fibronectin plating of cells associated with RhoA
activation. Rgnef2/2 MEF phenotypes were rescued by epitope-tagged Rgnef re-expression.
Conclusions: Rgnef2/2 MEF phenotypes were due to Rgnef loss and support an essential role for Rgnef in RhoA regulation
downstream of integrins in control of cell migration.
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Introduction
Directed cell migration is a physical process that requires
regulated changes in cell shape and adhesion to the extracellular
matrix (ECM) [1]. Sites of cell adhesion (termed focal adhesions,
FAs) are mediated by integrins, transmembrane receptors that
couple the ECM to the filamentous actin cytoskeleton [2]. The
migration cycle begins with membrane protrusion, FA formation
at the cell front, FA linkage to the actin cytoskeleton, the
generation of traction and forward cell movement, followed by
disassembly of FAs at the cell rear [3]. At FAs, integrins bind ECM
proteins such as fibronectin (FN) and multi-protein signaling
complexes form in association with integrin cytoplasmic domains
that drive the migration cycle in part through regulation of Rho-
family GTPase activity [4].
Rho GTPases, including Cdc42, Rac1, RhoA, and RhoC are
key effectors of cell migration and actin cytoskeletal dynamics that
function as molecular switches cycling between an inactive GDP-
bound state and an active GTP-bound form that interacts with
downstream targets [5]. Rho GTPases are activated by guanine
nucleotide exchange factors (GEFs) that catalyze the exchange of
GDP for GTP [6]. Rho GTPases return to an inactive state upon
hydrolysis of GTP to GDP, a reaction enhanced by GTPase-
activating proteins (GAPs) [7]. Initial steps of integrin binding to
FN and cell spreading are associated with transient RhoA
inhibition followed by a more prolonged period of RhoA
activation associated FA formation and the generation of cell
tension [8]. Analysis of knockout fibroblasts revealed the
importance of both focal adhesion kinase (FAK) and Src-family
tyrosine kinases in promoting signals leading to transient RhoA
inhibition downstream of integrins [9,10]. Integrin-stimulated Src
and FAK tyrosine phosphorylation of p190RhoGAP is associated
with elevated RhoGAP activity and the transient inhibition of
RhoA needed for efficient cell motility-polarity [11,12,13,14]. Our
understanding of GEFs involved in facilitating RhoA reactivation
and FA formation upon FN adhesion remains incomplete.
There are at least 69 different proteins that comprise an
extended GEF family [6,15]. These GEFs contain a conserved
region first identified in a transforming gene from diffuse B-cell-
lymphoma (Dbl), designated Dbl-homology (DH) [16,17]. Many
GEFs also contain a pleckstrin homology (PH) domain, known to
bind phosphorylated phosphoinositide lipids and promote mem-
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unit promoting nucleotide exchange, but specificity for Rho-
GTPase regulation is mediated by additional targeting interactions
unique to different GEF proteins [19].
For integrin signaling, knockdown experiments have identified
Lsc/p115RhoGEF, LARG, GEF-H1, and p190RhoGEF (Rgnef)
as contributing to RhoA activation, actin stress fiber, and FA
formation in response to cell adhesion to FN [20,21,22]. LARG
and GEF-H1 have been linked to RhoA activation in response to
mechanical forces on integrins [23]. Over-expression analyses
have revealed partial co-localization of p115RhoGEF, LARG, and
Rgnef with integrins at FAs [20,21]. Rgnef binds directly to FAK
through a motif in the Rgnef C-terminal domain, a feature not
shared with other GEFs [24]. FAK binding directs Rgnef
localization to FAs within fibroblasts and this FAK-Rgnef linkage
also functions to promote colon carcinoma motility, invasion, and
tumor progression [25]. Thus, FAK associates with both GAPs
and GEFs in the spatial and temporal control of RhoA regulation
and cell motility [26].
Herein, we present results from the generation of an Rgnef
knockout mouse. Loss of Rgnef expression does not prevent
embryonic development, but numbers of Rgnef2/2 mice
obtained at weaning were of smaller size and significantly less in
numbers compared to expected Mendelian ratios from Rgnef+/2
crosses. Primary Rgnef2/2 mouse embryo fibroblasts (MEFs)
exhibited reduced haptotaxis migration, wound closure motility,
and FA numbers formed on FN. Affinity-binding assays to a
nucleotide-free RhoA (G17A) mutant revealed Rgnef activation at
60 min after FN stimulation and Rgnef2/2 MEFs exhibited
significantly reduced RhoA GTP binding at 60 to 120 min on FN
compared to normal Rgnef+/+ MEFs. As Rgnef re-expression
rescued Rgnef2/2 MEF phenotypic defects, these studies
establish the importance of Rgnef in RhoA regulation, FA
establishment, and cell migration downstream of integrins.
Results
Generation of Rgnef knockout mice
Rgnef, originally termed p190RhoGEF [27], is comprised of N-
terminal leucine-rich and cysteine-rich zinc-finger-like regions of
unknown function, a central DH-PH domain catalytic region, a
FAK interaction motif, and a C-terminal potential coiled-coil
region that binds other proteins [28,29,30,31] (Fig. 1A). To
determine the necessity of Rgnef expression in mouse develop-
ment, a transgenic mouse model was created by homologous
recombination whereby Rgnef exon 24 (coding for part of the DH
domain) was flanked by loxP sequences (Rgnef
flox) (Fig. 1B, Fig.
S1). Initial crosses revealed that homozygous Rgnef
flox/flox mice
developed normally, were fertile, and displayed no detectable
phenotype (data not shown).
Rgnef
flox/flox mice were then crossed with cytomegalovirus
(CMV) Cre transgenic mice (Cre+) [32] to ubiquitously recombine
LoxP sites and inactivate Rgnef expression in all tissues during
early development and in germ cells (Fig. 1B). Heterozygous
Rgnef
WT/flox (Cre+) crosses were performed and Cre-driven Rgnef
recombination was confirmed by PCR genotyping of tail-extracted
DNA from 3 week old littermates (Fig. 1C and Table 1). Reverse-
transcriptase (RT) initiated PCR using primers directed 59 of
Rgnef exon 24 (Fig. 1D) or protein immunoblotting (Fig. 1E) did
not detect the presence of Rgnef mRNA or protein in Rgnef
flox/flox
(Cre+) embryos extracted at e13.5 compared to Rgnef
WT/WT
(Cre+) controls. Although the numbers of Rgnef
WT/WT (Cre+),
Rgnef
WT/flox (Cre+), and Rgnef
flox/flox (Cre+) mice analyzed at
e13.5 fit normal Mendelian ratios, Rgnef
flox/flox (Cre+) mice at 3
weeks of age were significantly less than expected (Table 1) and
exhibited an overall smaller body size (Fig. 1F). The cause of this
phenotype remains unknown. However, Rgnef
flox/flox (Cre+) mice
(herein termed Rgnef2/2) grow the same size as Rgnef
WT/WT
(Cre+) mice (herein termed Rgnef+/+) by 6 to 8 weeks and are
fertile. From continued heterozygous matings, decreased Rgnef2/
2 offspring frequency is still observed when Cre is not present
(Rgnef+/+: 31%, n=13; Rgnef+/2: 49%, n=20; Rgnef2/2:
20%, n=8). This result is consistent with a partial lethal perinatal
phenotype of Rgnef2/2 mice being independent of Cre
expression.
At e13.5, Rgnef protein expression is maximally detected within
the developing brain by immunohistochemical staining with
antibodies to Rgnef (Fig. 2A). This is consistent with findings of
Rgnef protein expression within mouse brain tissue extracts at e13
and e19 [24]. Immunoblotting analyses of adult mouse tissue
revealed the highest relative level of Rgnef protein expression in
the brain, lung, ovary, and spleen (Fig. 2B). Low but detectable
levels of Rgnef were found in heart, testes, and kidney. Upon over-
exposure, an Rgnef band was detected in liver but not in skeletal
muscle. These results are consistent with a low ubiquitous pattern
of Rgnef expression in most tissues with higher Rgnef levels
present in specific organs.
Rgnef is required for normal MEF cell motility
To assess the necessity of Rgnef in cell function, primary MEFs
were isolated from e13.5 Rgnef2/2 and Rgnef+/+ embryos
(Fig. 3 and Fig. S2). Rgnef mRNA (Fig. S2) and ,190 kDa Rgnef
protein (Fig. 3A) were detected in MEFs from Rgnef+/+ but not
Rgnef2/2 littermates. Although total FAK levels were slightly
increased and verified by densitometry analyses from indepen-
dently-derived cell lines, no changes were detected in the FAK
paralog Pyk2, related GEF-H1/Lfc, or cytoskeletal protein paxillin
expression (Fig. 3A). Generation of N-terminal directed polyclonal
antibodies to Rgnef did not detect any truncated protein products
in Rgnef+/+ or Rgnef2/2 MEFs (Fig. 3B). This is consistent with
no Rgnef mRNA detected using 59 end-directed RT-PCR analyses
(Fig. 1D). Taken together, these results support the conclusion that
floxed deletion of Rgnef exon 24 results in the absence of Rgnef
expression in embryos and primary MEFs.
Primary MEFs were immortalized via large T antigen
expression to facilitate cell culture analyses. Since knockdown
experiments MEFs [21] and human colon carcinoma cells [25]
support the importance of Rgnef in promoting cell motility,
Rgnef2/2 and Rgnef+/+ MEFs were analyzed by scratch wound
(Figs. 3C and D, Videos S1 and S2) and FN-stimulated haptotaxis
transwell (Fig. 3E) migration assays. In both assays, lack of Rgnef
expression significantly inhibited cell movement.
Rgnef facilitates integrin-initiated FA establishment
Efficient cell migration requires precise FA assembly-disassem-
bly and stress fiber for tension generation [3,4]. MEFs will spread
and form FAs as detected by paxillin staining with integrated actin
stress fibers by 60 to 90 min when replated onto FN-coated
surfaces [2]. Rgnef+/+ and Rgnef2/2 MEFs were FN replated
and analyzed for differences in FA numbers and size at 90 and
120 min (Figs. 4 and 5). Whereas Rgnef2/2 MEFs spread
equally and exhibited no morphological differences to normal
MEFs, loss of Rgnef resulted in significantly fewer FAs at 90 and
120 min (Figs. 4 and 5). Adhesion formation is a dynamic process
that can result either in disassembly or maturation corresponding
to an increase in FA size [1]. At 90 min on FN, median Rgnef+/+
MEF FA size was 40 pixels compared to Rgnef2/2 MEFs at 30
pixels as determined by Cell Profiler software analyses (Fig. 4C). At
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pixels whereas Rgnef2/2 MEF FA size decreased to 20 pixels
(Fig. 5C). The difference in Rgnef+/+ and Rgnef2/2 FA size at
120 min was significant and may contribute to the motility defects
of Rgnef2/2 MEFs. Together, these results support the
importance of Rgnef in promoting FA establishment and size
after integrin binding to FN.
Rgnef activation parallels RhoA GTP binding upon FN
stimulation
Replating experiments with Rgnef+/+ and Rgnef2/2 MEFs
support the notion that Rgnef activity may influence FA dynamics.
Since adhesion to FN triggers the activation of Lsc/p115 and
LARG RhoGEFs within MEFs as determined by RhoGEF affinity
binding to a nucleotide-free mutant (G17A) of RhoA [20], similar
affinity pull-down experiments were performed to evaluate Rgnef
activation upon MEF binding to FN (Fig. 6A). Compared to
lysates of cells held in suspension or replated on FN for 30 min,
Rgnef was significantly activated and bound to GST-RhoA G17A
at 60, 90, and 120 min after FN stimulation (Fig. 6A). These
results show that Rgnef is activated within 60 min upon cell
binding to FN.
Initial MEF binding and spreading on FN is associated with
transient RhoA inhibition followed by a more prolonged period of
RhoA activation associated FA formation and the generation of
cell tension [8]. Analyses of RhoA GTP binding by GST-Rhotekin
Rho binding domain affinity pull-down assays revealed increases
at 60 and 90 min upon Rgnef+/+ MEF adhesion to FN (Figs. 6B
and C). Notably, this parallels the time course of Rgnef activation.
Importantly, RhoA GTP binding is significantly inhibited at both
Figure 1. Generation of Rgnef2/2 mice. (A) Rgnef schematic. Depicted are the N-terminal leucine-rich (Leu), zinc finger-like (Zn), Dbl- and
pleckstrin-homology (DH-PH), FAK binding region, and C-terminal coiled-coil (coil) domains. (B) Genetic targeting strategy to insert LoxP sites and a
neomycin selectable marker (Neo) around Rgnef exon 24 by homologous recombination (Rgnef
flox). Primer binding sites used for PCR screening are
indicated (see Table 3). Rgnef
flox/flox mice were crossed with transgenic (Tg) cytomegalorvirus-driven Cre (CMV-Cre) recombinase expressing mice to
inactivate Rgnef expression during early development (Rgnef
flox, Cre+). (C) Representative PCR genotyping of progeny from Rgnef
WT/flox (Cre+)
mouse crosses: Rgnef
WT/WT (582 bp), Rgnef
WT/flox (582 and 125 bp), and Rgnef
flox/flox (125 bp). Cre PCR genotyping (500 bp) is also shown. (D) No
truncated Rgnef mRNA transcript detected in Rgnef
flox/flox (Cre+) mice. Embryos were isolated at e13.5 from Rgnef
WT/flox Cre+ mouse crosses, total
RNA isolated, and analyzed by RT-PCR using primers 59 to deleted exon 24 (see Table 3) to Rgnef. GAPDH amplification is a positive control. (E) No
Rgnef protein expressed in Rgnef
flox/flox (Cre+) mice. Embryo lysates were immunoblotted with antibodies to Rgnef, FAK, and actin as a control. (F)
Representative image of male littermates showing reduced size of Rgnef
flox/flox (Cre+) mice at 4 weeks.
doi:10.1371/journal.pone.0037830.g001
Table 1. Genotypes of embryos obtained by Rgnef
WT/flox
(Cre+) crosses.
E13.5 (%) Born (%)
Rgnef WT/WT 10 (21%) 59 (30%)*
Rgnef WT/flox 28 (58%) 104 (53%)
Rgnef flox/flox 10 (21%) 35 (17%)*
Total 48 198
Indicated is the total number of mice obtained at embryonic age 13.5 and born
as determined at time of weaning (3 weeks). Pearson’s Chi squared analysis
(*p,0.05).
doi:10.1371/journal.pone.0037830.t001
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These results support the importance of Rgnef in facilitating RhoA
activation upon FN stimulation.
Rgnef promotes RhoA activation, increased FA numbers,
and cell motility
To determine that Rgnef2/2 MEF phenotypes are linked to
the loss of Rgnef expression, green fluorescent protein (GFP) or
GFP-Rgnef were transiently re-expressed in Rgnef2/2 MEFs as
a rescue strategy (Fig. 6D). GFP-Rgnef significantly increased
RhoA GTP binding at 60 and 90 min after Rgnef2/2 MEF
replating on FN compared to GFP alone (Fig. 6E). Whereas GFP
was primarily distributed in the cytoplasm, a portion of GFP-
Rgnef co-localized with paxillin at peripheral FAs when Rgnef2/
2 MEFs were analyzed by confocal microscopy at 90 min after
FN replating (Figs. 7A and B). GFP-Rgnef expression significantly
increased the number but not size of FAs formed after 90 min on
FN compared to GFP alone (Figs. 7C and D). In parallel, HA-
tagged Rgnef re-expression resulted in a 6-fold increase in
Rgnef2/2 MEF haptotaxis motility on FN after 3 h compared
to control-transfected cells (Fig. 7E). When analyzed by real time
Figure 2. Analyses of Rgnef protein expression. (A) Sagittal
sections of e13.5 Cre+ Rgnef
WT/WT Cre+ and Rgnef
flox/flox Cre+
littermate embryos were stained with antibodies to Rgnef, visualized by
horseradish peroxidase reactions using diaminobenzidine (DAB, brown).
Note loss of DAB staining in Rgnef
flox/flox Cre+ embryos. Scale is 1 mm.
(B) The indicated tissues from 10 week old mice were harvested, protein
lysates separated by SDS-PAGE, and the same membrane was cut into
sections and immunoblotted for Rgnef, a-tubulin and GAPDH.
doi:10.1371/journal.pone.0037830.g002
Figure 3. MEF motility requires Rgnef. (A) Protein lysates from
primary Rgnef+/+ and Rgnef2/2 MEFs were analyzed by immunoblot-
ting for Rgnef, FAK, Pyk2, Lfc (mouse GEFH1 homolog), paxillin, and
actin. Densitometry for FAK levels normalized to actin (n=3 indepen-
dently-derived cell lines). (B) Anti-Rgnef N-terminal domain antibodies
were used for immunoprecipitation and blotting of Rgnef+/+ and
Rgnef2/2 MEF lysates. Detection of a 190 kDa band in Rgnef+/+
lysates by N-terminal and C-terminal anti-Rgnef antibodies. No specific
or potentially truncated (117 kDa) bands were detected in Rgnef2/2
MEF lysates. Actin was used as loading control. (C) Phase contrast
images (from 0 and 8 h) from a scratch wound migration assay with
Rgnef+/+ and Rgnef2/2 MEFs. Scale is 100 mm. (D) Wound closure
motility was calculated by measuring the distance change between 0
and 8 h in time lapse experiments. Data is the mean percentage 6 SD
of four independent experiments (** p,0.01). (E) Haptotaxis chamber
motility on fibronectin was measured after 3 h. Data is the mean 6 SD
of three independent experiments normalized to Rgnef+/+ MEFs (**
p,0.01).
doi:10.1371/journal.pone.0037830.g003
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MEF motility on FN by significantly-increasing the speed and total
distance of cell movement compared to GFP-only cells (Figs. 7F–
H). Taken together, these results confirm the importance of Rgnef
in promoting RhoA activation, FA establishment, and cell motility
downstream of integrins.
Discussion
RhoA GTPase regulation in response to growth factor, G
protein linked, and integrin receptor stimuli plays key roles in the
formation and regulation of FAs at both leading and trailing edges
of migrating cells [4]. Transient knockdown studies have
implicated specific signaling pathways connected to the sub-family
of RhoA, RhoB, and RhoC GTPases in the control of cell
migration [33]. However, results from mouse genetic knockouts
(KOs) support the notion of functional overlap within this
RhoGTPase sub-family [34]. RhoB KO and RhoC KO mice
have no major developmental defects and MEFs derived from
these mice exhibit either minor alterations in actin stress fibers
(RhoC) or reduced motility and b1 integrin expression (RhoB)
[35,36]. Conditional KO of RhoA in keratinocytes showed that it
is not essential for skin development or wound healing in vivo, but
RhoA KO keratinocytes exhibit motility defects in culture [37]. In
contrast, analyses of RhoA KO MEFs revealed redundant
signaling roles with RhoB and RhoC in actomyosin regulation
in culture [38]. Thus, understanding the factors of Rho GTPase
sub-family regulation is complex and likely associated with the fact
that GEFs outnumber Rho GTPases [6]. Moreover, spatiotem-
poral signal integration within cells is important in the control of
cytoskeletal dynamics needed for efficient cell movement [4].
Here we provide the first characterization of an Rgnef KO
mouse. From heterozygous crosses, Rgnef2/2 mice are found at
expected Mendelian ratios at e13.5, but are born at lower than
expected Mendelian frequency and exhibit an overall smaller size
than Rgnef+/2 or Rgnef+/+ littermates. Gross analyses of
Rgnef2/2 offspring did not reveal apparent abnormalities and
this size difference was negligible by 6 to 8 weeks of age. We
Figure 4. Decreased FA number in Rgnef2/2 MEFs on fibronectin (FN) at 90 min. (A) Rgnef +/+ and Rgnef2/2 MEFs were plated onto
glass coverslips pre-coated with FN (10 mg/ml). Cells were fixed and analyzed for FA formation by paxillin staining (green), f-actin (phalloidin, red), and
nuclei were stained with Hoechst (blue) as shown in a merged image. Scale is 10 mm. Significantly-reduced adhesion number (B) and decreased
median adhesion size (C) in Rgnef2/2 compared to normal (Rgnef+/+) MEFs. Paxillin-stained points were enumerated as FAs by thresholding images
using Image J (v1.4) and FA size (pixels) was determined using Cell Profiler (v2.0). Box-and-whisker plots show distribution of the data: mean (black
square), median (middle line), 25
th percentile (bottom line), 75
th percentile (top line), and 5
th or 95
th percentiles (whiskers),* p,0.05.
doi:10.1371/journal.pone.0037830.g004
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development, but that some type of partial redundancy or
compensation may be occurring to lessen or bypass the
developmental or physiological restriction point between e13.5
and birth. Although it remains unclear whether the Rgnef KO
phenotype parallels RhoA inactivation, embryonic lethal pheno-
types are uncommon in other RhoGEF KO mouse models
(Table 2). Except for KO of AKAP13 (Brx) that results in heart
developmental defects [39] or Trio that results myofibril defects in
late embryonic development [40], other RhoGEF KOs have
either restricted hematopoietic or other non-lethal phenotypes
(Table 2). Despite transient knockdown studies implicating Lsc/
p115 RhoGEF and LARG in FN signaling to RhoA [20], mice
from these KOs were viable and fertile with either a leukocyte
homeostasis defect [41,42] or smooth muscle hypertension defects
that did not necessarily involve integrin signaling connections [43].
Interestingly, as observed with Rgnef KO mice, KOs of the RhoA
effector proteins ROCK1 or ROCK2 (Rho-associated protein
kinases) also result in partial embryo lethality and birth of small
pups [44,45]. ROCK2 loss was associated with late placental
dysfunction and ROCK1 loss with cellular actomyosin bundling
defects. Future studies of Rgnef KO embryos in utero between
e13.5 and birth will be focused on identifying potential phenotypes
as a means to link Rgnef to RhoA signaling in vivo.
Many of the restricted hematopoietic or neural defects
associated with RhoGEF KOs are associated with alterations in
cell movement (Table 2). Surprisingly, there are no reports
characterizing cell motility defects RhoGEF KO MEFs in cell
culture. It is established that initial MEF binding and spreading on
FN is associated with transient RhoA inhibition followed by a
more prolonged period of RhoA activation associated FA
formation and the generation of cell tension [8,10]. When
compared to wildtype littermate MEFs, Rgnef KO significantly
inhibited haptotaxis migration, wound closure motility, FA
Figure 5. Decreased FA number and size in Rgnef2/2 MEFs on fibronectin (FN) at 120 min. (A) Rgnef+/+ and Rgnef2/2 MEFs were
plated onto glass coverslips pre-coated with FN (10 mg/ml). Cells were fixed and analyzed for FA formation by paxillin staining (green), f-actin
(phalloidin, red), and nuclei were stained with Hoechst (blue) as shown in a merged image. Scale is 10 mm. Significantly-reduced adhesion number (B)
and size (C) in Rgnef2/2 compared to normal (Rgnef+/+) MEFs. Paxillin-stained points were enumerated as FAs by thresholding images using Image
J (v1.4) and FA size (pixels) was determined using Cell Profiler (v2.0). Box-and-whisker plots show distribution of the data: mean (black square), median
(middle line), 25
th percentile (bottom line), 75
th percentile (top line), and 5
th or 95
th percentiles (whiskers),* p,0.05.
doi:10.1371/journal.pone.0037830.g005
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PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e37830Figure 6. Rgnef activation corresponds with RhoA GTP binding upon FN stimulation. (A) Evaluation of Rgnef activation in lysates of
normal MEFs held in suspension for 30 min and then replated onto 10 mg/ml FN for the indicated times. Pull-down assays using GST-RhoA (G17A)
and Rgnef immunoblotting reveals binding at 60 to 120 min after FN stimulation (top). Total Rgnef and actin levels shown by immunoblotting whole
cell lysates (bottom). Quantitation of the bound versus total Rgnef by densitometry is shown as the mean 6 SD of three independent experiments (*
p,0.05, by one-way ANOVA with Tukey post-hoc analysis). (B) Rgnef loss reduces RhoA activation upon FN replating. GTP-bound RhoA was
determined in lysates of suspended or FN-stimulated normal (Rgnef+/+) or Rgnef2/2 MEFs by GST-Rho binding domain affinity pull-down assays
and immunoblotting for RhoA. Whole cell lysate samples were immunoblotted for total RhoA. (C) Quantitation of suspended (0 min) FN-associated
RhoA GTP binding by densitometry are means 6 SD of three independent experiments expressed relative to total RhoA levels in lysates (** p,0.01,
*** p,0.001). (D) Transient expression of GFP or GFP-Rgnef in Rgnef2/2 MEFs as detected by GFP or actin immunoblotting or whole cell lysates.
Actin and paxillin levels are shown as controls. (E) Rgnef2/2 MEFs were transiently-transfected with GFP or GFP-Rgnef, held in suspension for 30 min,
and then replated onto 10 mg/ml FN for the indicated times. GTP-bound RhoA was determined by affinity pull-down assays, RhoA immunoblotting,
and densitometry. Values are means 6 SD of three independent experiments expressed relative to total RhoA levels in lysates (* p,0.05).
doi:10.1371/journal.pone.0037830.g006
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e37830Figure 7. Rgnef re-expression rescues RhoA activation, FA establishment, and motility defects of Rgnef2/2 MEFs. (A) GFP control
transfected Rgnef2/2 MEFs were plated on FN for 90 min, fixed, and analyzed for GFP (green), paxillin (red), and nuclear (DAPI, blue) localization.
Scale is 10 mm. Inset, enlarged area of FA staining at periphery of cell (white box). (B) GFP-Rgnef transfected Rgnef2/2 MEFs were plated on FN for
90 min, fixed, and analyzed for GFP (green), paxillin (red), and nuclear (DAPI, blue) localization. Scale is 10 mm. Note increased paxillin staining at FAs
in GFP-Rgnef-expressing MEFs. Inset, enlarged area of FA staining at periphery of cell (white box). (C) Paxillin-stained points at 90 min on FN were
enumerated as FAs by thresholding images using Image J (v1.4) in GFP or GFP-Rgnef transfected Rgnef2/2 MEFs (** p,0.01). (D) The size of paxillin-
stained points at 90 min on FN enumerated as FAs in C were measured using Cell Profiler (v2.0) in GFP or GFP-Rgnef transfected Rgnef2/2 MEFs. (C
and D) Box-and-whisker plots show distribution of the data: mean (black square), median (middle line), 25
th percentile (bottom line), 75
th percentile
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In WT MEFs, Rgnef activation occurs within 60 min upon FN
stimulation and this parallels the time course of FN-induced RhoA
activation. Importantly, Rgnef KO MEF phenotypes were rescued
by Rgnef re-expression; demonstrating that this was a direct result
of Rgnef loss. Moreover, our results with Rgnef KO MEFs are in
complete agreement with previous studies using short-hairpin
RNA interference to knockdown Rgnef expression [21] that
resulted in fibroblasts that exhibited motility defects on FN with
fewer FAs formed but no alterations in cell spreading.
With regard to the processes involved in FA formation and the
control of cell migration, it is important to note that RhoA
GTPase regulation is a cycle and that inhibition or constitutive
activation of Rho GTPases result in cell migration defects. Too
many or too few adhesions formed can prevent efficient cell
movement [46]. Moreover, it is overly simplistic to equate
decreased FA formation and size differences observed in Rgnef
KO MEFs to the inhibition of cell migration. Future studies
evaluating the kinetics of FA formation and turnover at both
leading and trailing cell projections, studies evaluating the
processes of FA maturation or tension generation, and potential
differences in adhesome protein content may lead to further
mechanistic insights associated with Rgnef KO MEF motility
defects. Moreover, Rgnef contains a unique region that binds to
FAK and is required for Rgnef localization to FAs [21,24]. It has
been hypothesized that this Rgnef linkage to FAK is key to FN-
induced RhoA regulation and future re-expression studies using
Rgnef KO MEFs will serve as a powerful system to elucidate the
molecular connections of this signaling pathway.
In addition to facilitating RhoA in MEFs, Rgnef expression is
elevated as a function of colon cancer tumor grade and stage [25].
A complex of Rgnef, FAK, and paxillin promote colon carcinoma
tumor cell motility and matrix degradation in vitro with
corresponding increases in tumor growth and surrounding tissue
invasion in vivo [25]. Cellular projections that promote matrix
degradation are termed invadopodia and Rgnef localizes around
these sites to activate RhoC in breast carcinoma cells [47].
Whether Rgnef signaling connections linked to tumor progression
involve RhoA or RhoC remain unknown. As Rgnef KO mice are
fertile, analyses of these mice crossed to spontaneous mouse tumor
models will serve to elucidate the role of Rgnef in promoting
tumor invasion and progression.
Materials and Methods
Ethics Statement
All procedures were approved by UCSD Institutional Animal
Care and Use Committee and mice were maintained in
accordance with Association for Assessment and Accreditation of
Laboratory Animal Care-approved guidelines.
(top line), and 5
th or 95
th percentiles (whiskers). (E) Rgnef2/2 MEFs were transfected with plasmids expressing LacZ plus empty vector (control) or
LacZ and Rgnef and then analyzed for haptotaxis FN motility (3 h). Motile cells were analyzed for b-galactosidase activity, enumerated, and results are
the mean fold change 6 SD compared to control transfected cells from four independent experiments (** p,0.01). (F–H) GFP or GFP-Rgnef
expressing Rgnef2/2 MEFs on 1 ug/ml FN were analyzed by real time microscopy over 5 hours for random motility. (F) Migration paths of 4
representative cells were determined by cell nuclei position and migration of origin was superimposed at 0. Migration distance in mm (G) and overall
speed in mm/sec (H) was determined by tracking cells and calculated using Slidebook (v5.0) software (n=34 per group, values are means 6 SD, and
p=0.001).
doi:10.1371/journal.pone.0037830.g007
Table 2. Cytoskeletal-associated RhoA sub-family GEF mouse knockouts.
GEF Target GTPase Tissue-Cell Expression Knockout Phenotype References
Abr* RhoA, Rac1, Cdc42 ubiquitous Viable and fertile, cerebellar
and vestibular defects with
combined Bcr loss
[49,50]
Arhgef1/Lsc/p115RhoGEF RhoA hematopoietic Viable and fertile, leukocyte
homeostasis defects
[41,42]
Arhgef5/Tim RhoA/B, (low RhoC/G) ubiquitous Viable and fertile, decrease in
dendritic cell migration
[51]
Arhgef12/LARG RhoA ubiquitous Viable and fertile, smooth
muscle hypertension defects
[43]
Dbl/Mcf2 RhoA/B/C/G, Rac1, Cdc42 Neural, gonads low level
in other tissues
Viable and fertile, dendrite
elongation defect
[52]
Lbc/AKAP13/Brx RhoA ubiquitous Early embryonic lethality with
heart development defects
[39]
Rgnef/p190RhoGEF RhoA/C ubiquitous Viable and fertile, decreased
numbers and size at birth
Trio RhoA/G, Rac1 ubiquitous Embryonic lethal, muscle
and neural tissue defects
[40]
Vav1 RhoA/G, Rac1, Cdc42 hematopoietic Viable and fertile, T cell
development defects
[53,54]
Vav2 RhoA/G, Rac1, Cdc42 ubiquitous Viable and fertile, B cell defects
combined with Vav1 loss
[55]
Vav3 RhoA/G, Rac1, Cdc42 ubiquitous Viable and fertile, T- and B-cell defects
with combined Vav1/2 loss
[56]
*also functions as a GTPase-activating protein.
doi:10.1371/journal.pone.0037830.t002
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Rgnef exon 24 floxed mice were created by homologous
recombination (InGenious Targeting Laboratory, Stony Brook,
NY) and the cloning strategy depicted (Fig. 1B). An 8.64 kb region
(encompassing Rgnef exons 23–26, Ensembl release 65 - Dec
2011) from a C57BL/6 BAC clone (RPCI23 388E6) was used to
construct the targeting vector in pGK-gb2 loxP/FRT Neo. The
region was designed such that the short homology arm (SA)
extends about 1.42 kb 59 to exon 24. The long homology arm (LA)
ends 39 to exon 24 and is 6.77 kb long. The loxP flanked Neo
cassette is inserted on the 59 side of exon 24 and the single loxP site
is inserted at the 39 side of exon 24. The target region is 455 bp
and includes exon 24 (Fig. S1A). Targeting vector was confirmed
by restriction digest and sequencing after each modification. The
targeting vector was subcloned into pSP72 prior to linearization
(NotI) and electroporation into mouse BA1 (C57BL/6 x129/
SvEv) hybrid embryonic stem (ES) cells. The total size of the
targeting construct (including vector backbone and Neo cassette)
was 12.84 kb.
After G418 selection, surviving ES clones were expanded for
PCR analysis to identify recombinants. Screening primers A1 and
A2 were designed upstream of the short homology arm outside the
59 region used to generate the targeting construct. A list of PCR
primers used is provided in Table 3. PCR reactions using A1 or
A2 with the UNI primer (located within the Neo cassette) amplify
1.84 and 1.96 kb fragments, respectively. The control PCR
reaction was performed using the internal targeting vector primers
AT1 and AT2, which are located at the 59 and 39 ends,
respectively, of the SA. This amplifies a product 1.17 kb in size.
Individual clones from positive pooled samples were screened
using the A2 and UNI primers. Five positive SA recombinant
clones were identified by a 1.8 kb PCR fragment (Fig. S1B) and
sequenced for integration using the OUT1 primer. Confirmation
of integration of LA region was performed by PCR using LAN1
and Lox1 (Fig. S1B) or SDL2 and Lox1 primers and sequenced
using the LAN1 and OUT1 primers to confirm the presence of the
third LoxP site. A secondary confirmation of positive clones was
performed by Southern Blotting analyses of DNA digested with
StuI using a probe targeted against the 39 LA region (Fig. S1C).
Two confirmed clones (252 and 362) were microinjected into
C57BL/6 blastocysts. Resulting chimeras with a high percentage
agouti coat color were mated to wild-type C57BL/6 mice to
generate F1 heterozygous offspring that were genotyped using
primers flanking the neomycin cassette insertion site.
Rgnef
flox/flox mice were normal, fertile, and were mated to
CMV-Cre mice (B6.C-Tg(CMV-cre)1Cgn/J, Jackson Laboratory)
to remove the neomycin cassette and Rgnef exon 24. PCR
screening for Cre was performed as described [32]. Pregnant
females from timed heterozygous Rgnef
WT/flox (Cre+) crosses
were euthanized and embryos harvested at embryonic day (e)13.5
for RNA, protein, and primary MEF isolation from Rgnef
flox/flox
(Cre+) (Rgnef2/2) and Rgnef
WT/WT (Cre+) (Rgnef+/+)
littermates. Genotypes were confirmed by PCR using DNA
extracted from embryo tissue.
Genotyping and Reverse Transcriptase PCR (RT-PCR)
Genotyping conditions were 94uC for 5 minutes, followed by 35
cycles at 94uC for 30 seconds, either 60uC, 58uC, or 56uC (for
Neo, Rgnef, or Cre, respectively) for 30 seconds, and 72uC for
1 minute, followed by a 10 minute extension at 72uC.
For RT-PCR, poly-A RNA was isolated using RNeasy (Qiagen)
and cDNA was generated using 1 mg RNA and the SuperScript III
first-strand synthesis system (Invitrogen). PCR reaction conditions
were performed using a BioRad S1000 thermal cycler and GoTaq
green master mix (Promega). Primers used are shown in Table 3.
Reagents and Antibodies
Rabbit polyclonal affinity-purified anti-peptide antibodies to the
C-terminal region of Rgnef were created and used as described
[25]. Rabbit polyclonal affinity-purified antibodies directed to
Rgnef N-terminal domain residues 265–281 (IKLFRKYFW-
DRAFLVKAC) were generated by 21st Century Biochemicals.
Antibodies to b-actin (AC-17) and a-tubulin (DM1A) were from
Sigma. Anti-FAK (4.47 clone) was from Millipore. Pyk2 (clone 11)
and paxillin (clone M107) antibodies were from BD Biosciences.
Antibodies to RhoA (26C4) and GEF-H1/Lfc (Y-20) were from
Santa Cruz Biotechnology. Anti-GFP antibodies were from
Covance Research. AlexaFluor-488 and AlexaFluor-594 labeled
antibodies and Texas Red-phalloidin were from Invitrogen. FN
was purified from blood plasma as described [48] or purchased
(Sigma).
Immunohistochemistry
Embryos were fixed in 4% paraformaldehyde (4uC, overnight)
and dehydrated in ethanol/water washes prior to paraffin
embedding. Sections (10 mm) were floated onto SuperFrost Plus
slides (Fisher) and dried overnight at 37uC. Prior to staining, slides
were incubated at 60uC for 30 min, deparaffinized in xylene
washes, and rehydrated in ethanol/water washes. Antigen retrieval
(boiling for 10 min in 10 mM sodium citrate) and peroxidase
quenching (0.3% hydrogen peroxide for 10 min) were performed.
Sections were incubated in Blocking Buffer (PBS with 5% normal
goat serum, 1% BSA, and 0.3% Triton X-100) for 60 min at room
temperature and then incubated in anti-Rgnef antibodies (1:200 in
Blocking Buffer) overnight at 4uC. Biotinylated goat-anti-rabbit
IgG (1:300), Vectastain ABC elite, and diaminobenzidine (Vector
Labs) were used to visualize Rgnef antibody binding. Images were
acquired using an Olympus IX81 microscope (46 objective), an
Infinity1 color CCD camera, and whole embryos images stitched
together using Adobe Photoshop CS3 software.
Cells and Constructs
Primary mouse embryo fibroblasts (MEFs) were isolated from
e13.5 embryo Rgnef
flox/flox (Cre+) and Rgnef
WT/WT (Cre+)
littermates. Briefly, heads were removed for genotyping, tissue was
minced with a razor blade, incubated in 0.25% trypsin-EDTA
(Gibco) for 5 min at 37uC, and digested with DNase (100 Units/
ml). Cells were collected by centrifugation, and grown on 0.1%
gelatin-coated culture dishes in Dulbecco’s modified Eagle’s
medium (DMEM) containing 10% fetal bovine serum (FBS),
penicillin (100 units/ml), streptomycin (100 mg/ml), MEM non-
essential amino acids, sodium pyruvate (1 mM), and ciprofloxacin
(20 mg/ml). Primary MEFs were immortalized by retrovirus-
mediated large T-antigen (Addgene) expression followed by
puromycin selection. Cells were transfected with pEGFP-C1
(Clontech), pEGFP-Rgnef [21], pcDNA3-LacZ (Invitrogen), and
pcDNA-HA-Rgnef [24] using JetPrime (Polyplus Transfection,
Inc) per the manufacturer’s instructions. pCDH-MCS1-GFP and
pCDH-MCS1-GFP-Rgnef were used to produce lentivirus as
described [21] and Rgnef2/2 MEFs were transduced according
to standard methods (System Biosciences).
Biochemical Analyses
For signaling, haptotaxis cell motility or imaging experiments,
cells were starved (0.5% serum) 16 h at sub-confluent densities,
treated with 0.06% trypsin and 2 mM EDTA in PBS (2.5 min at
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inhibitor (0.5 mg/ml) with 0.25% bovine serum albumin (BSA) in
DMEM, collected by centrifugation, resuspended in Migration
Medium (DMEM with 0.5% BSA), enumerated (ViCell XR,
Beckman-Coulter), and held at 37uC( 2 610
5 cells/ml) for 1 h.
Acid-washed glass coverslips or plastic culture dishes were coated
with FN (10 mg/ml in PBS) overnight, blocked with 1% BSA in
PBS for 30 min, and pre-heated to 37uC prior to use. Whole cell
lysates were prepared after the indicated times in Extraction Buffer
containing 50 mM Hepes, pH 7.4, 150 mM NaCl, 1.5 mM
MgCl2, 1 mM EGTA, 10 mM sodium pyrophosphate, 100 mM
NaF, 10% glycerol, 1% Triton-X-100, 1% SDS, 0.5 mM
orthovanadate with phosphatase and protease inhibitors. For
immunoprecipitation analyses, lysates were diluted 2-fold in
HNTG buffer (50 mM Hepes, pH 7.4, 150 mM NaCl, 0.1%
Triton, 10% glycerol), incubated with antibodies (1 mg) for 3 h at
4uC, antibodies collected with Protein A Plus (Millipore) agarose
beads, and beads washed at 4uC in 1% Triton-only Extraction
Buffer, followed by washes with HNTG buffer, and resolved by
SDS-PAGE. GST-Rhotekin Rho binding domain (RBD) and
GST-RhoA (G17A) were expressed in bacteria and purified as
described [20,21]. Pull down assays were performed using 20 mg
GST-RBD or GST-RhoA G17A bound to glutathione agarose for
60 min at 4uC and then binding determined by RhoA or Rgnef
immunoblotting, respectively.
Cell Migration
Haptotaxis. For transient transfection studies, cells were co-
transfected with a pCDNA3-LacZ, pCDNA3-Rgnef, or pCDNA
empty vector and evaluated after 36 h. MilliCell chambers (8 mm
pores; Millipore) were coated on the membrane underside with FN
(10 mg/ml) in Migration Medium for 2 h, washed with PBS, and
air dried (30 min) prior to use. Cells were collected as described
above, 10
5 cells in 0.3 ml were added to each MilliCell chamber,
units were placed into 24-well plates containing 0.4 ml Migration
Medium, and incubated for 3 h at 37uC. Cells on the lower
membrane surface were fixed and visualized either by crystal violet
staining or analyzed for b-galactosidase activity using X-gal as a
substrate. Cells per microscopic field were counted (9 fields per
chamber) and mean values were obtained from three individual
chambers for each experimental point per assay.
Wound healing. Glass bottom dishes (MatTek) were coated
with FN (1 mg/ml), cells were plated at a subconfluent density
(75%), and after 24 h, cells were serum starved overnight,
wounded with a pipette tip, washed with PBS, and incubated in
growth media containing 0.5 mg/ml of mitomycin-C prior to
imaging. Phase contrast images of cells were acquired every
15 min in a humidified 5% CO2 environment at 37uC using an
Olympus IX51 microscope, XY-controlled stage with Z focus
drive (Olympus), 106objective (UPLFL, 0.30 NA), and an Orca-
ER camera (Hamamatsu) controlled by Slidebook (v5.0) software.
Table 3. Primers for Rgnef and CMV Cre mouse genotyping and transcript analysis.
Primer Sequence Notes
A1 59-GTAGCCAGCCCTCCCAACAC-39 forward, short arm of Rgnef flox transgene
A2 59-GATGGTGGAAGGCATTCTAAGTCC-39 forward, short arm of Rgnef flox transgene
AT1 59-GATCCTGTTAGGCTGGCCCTTTC-39 forward, Rgnef exon 23
AT2 59-CTGAGCATGCCCACTATCTGCTTTG-39 reverse, short arm of Rgnef flox transgene
OUT1 59-GATTAAGTAGAAAGGGCCAGCCTAAC-39 reverse, Rgnef exon 23
SDL2 59-CCTGTGAGCAAGCTTTTAAAGCCTC-39 forward, between exon 24 and 39 LoxP site
LOX1 59-GCTCAGGATTCCCCTTTGGC-39 reverse, long arm of Rgnef flox transgene
LAN1 59-CCAGAGGCCACTTGTGTGAGC-39 forward, Neo cassette in Rgnef flox transgene
UNI 59-AGCGCATCGCCTTCTATCGCCTTC-39 reverse, Neo cassette in Rgnef flox transgene
PB3 59-GTAGCCAGCCCTCCCAACAC-39 forward, southern probe ES cell confirmation
PB4 59-CTGAGCATGCCCACTATCTGCTTTG-39 reverse, southern probe ES cell confirmation
RGNEF GENO FWD 59-ACTGCAGATCAGCATGTCTTG-39 genotyping, 582 bp wild-type and/or 125 bp
recombined flox allele bands
RGNEF GENO REV 59-GCTGCTATCTCCAAACGCTAT-39
CRE FWD 59-TCGATGCAACGAGTGATGAG-39 genotyping, 500 bp band in Cre+ mice
CRE REV 59-TTCGGCTATACGTAACAGGG-39
NEO FWD 59-ACCTTGCTCCTGCCGAGAAAGTAT-39 genotyping, Rgnef flox transgene, 520 bp band
NEO REV 59-AGACGTCGCTTGGTCGGTCTTTAT-39
RGNEF RT FWD 59-CTGCAGCCATCACAAAG-39 RT-PCR, amplifies Rgnef 2957 bp-3141 bp,184 bp
band
RGNEF RT REV 59-ACTGCAGGATCCTTTCCA-39
GAPDH RT FWD 59-ATGGTGAAGGTCGGTGTGAACG-39 RT-PCR, amplifies GAPDH 51 bp 261 bp, 210 bp
band
GAPDH RT REV 59-GCTTCCCGTTGATGACAAGCT-39
RGNEF 59RT FWD 59-TGACCAGCCCACGGAACAAATCTA-39 RT-PCR, amplifies Rgnef 1990 bp-2151 bp, 161 bp
band
RGNEF 59RT REV 59-AGTTGGCACACTGGAGTGACTCTT-39
doi:10.1371/journal.pone.0037830.t003
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between 0 and 8 h.
Random migration. 1610
4 cells were seeded onto fibronec-
tin (FN)-coated (1 mg/ml) 6-well plates in growth media for 8 h,
then serum-starved overnight. Media was replaced with growth
media, phase contrast and GFP fluorescent images were collected
at 5-min intervals over 5 h with a 106lens on an automated stage
(Olympus IX51) at 37uC with humidity and CO2 regulation.
Slidebook (v5.0) software was used to track cell trajectories by
nuclear position over time, calculate distance traveled, and
average speed of 34 cells per group.
Immunofluorescence
Cells replated for the indicated time on FN-coated (10 mg/ml)
acid-washed glass coverslips (as above) were fixed in 3.7%
paraformaldehyde (10 min), permeabilized with 0.1% Triton X-
100 in PBS (10 min) and incubated in blocking buffer (2% BSA in
PBS) for 1 h. Paxillin antibodies were diluted (1:300) in blocking
buffer and incubated overnight at 4uC. Coverslips were washed in
PBS, incubated with AlexaFluor-488 or -594 goat anti-mouse
secondary antibodies, Texas Red-Phalloidin, 49-6-Diamidino-2-
phenylindole (DAPI) or Hoechst 33342 (Invitrogen) diluted in
blocking buffer (30 min), and mounted using Vectashield (Vector
Labs). Images were acquired sequentially using a mercury lamp
source, multiband dichroic, single-band exciter, and single band
emitter filter sets (Chroma) on dual filter wheels, an Olympus
IX81 spinning disc confocal microscope at 606 (PlanApo, N.A.
1.42) and an Orca-AG camera (Hamamatsu) controlled by
Slidebook (v5.0) software. Files were cropped, pseudocolored,
and adjusted using Adobe Photoshop CS3. Adhesion size (pixels)
and number within a cell were determined by analysis of paxillin
staining using Cell Profiler (v2.0, Broad Institute) using a pipeline
to threshold images and reduce background fluorescent staining in
at least 10 cells per group or by using Image J (v1.4).
Statistical analyses
Data were analyzed using unpaired Students t-test or one-way
ANOVA where indicated with GraphPad Prism (5.0 d). Signifi-
cance was determined at a p value less than 0.05.
Supporting Information
Figure S1 Schematic of Rgnef targeting and embryonic
stem (ES) cell confirmation. (A) Shown is the insertion of the
neomycin (Neo) cassette 59 to Rgnef exon 24, loxP sites (triangles),
short arm (SA) and long arm (LA) homology regions, 59 and 39
genomic regions (dashed lines), and the various primers used for
PCR screening of recombinant clones. Primer sequences are listed
in Table 3.(B) PCR confirmation of ES clone recombination. A1
and UNI primers were used to amplify a 1.8 kb sequence within
the short arm (left). Lox and Lan1 primers were used to amplify a
1.1 kb band within the long arm (right). (C) Southern blot
confirmation of ES clone recombination. StuI-digested DNA was
electrophoretically-separated on a 0.8% agarose gel, transferred to
nylon membrane, and hybridized with a probe generated by
primers PB3 and PB4 to give a 19.1 kb band for wild type and a
9.4 kb band for the recombined allele. ES clones 252 and 362
were used for blastocyst injection.
(TIF)
Figure S2 MEFs were generated from Rgnef+/+ and
Rgnef2/2 embryos. (A) Rgnef and Cre genotyping of primary
normal (Rgnef+/+) and Rgnef2/2 MEFs isolated from e13.5
embryos and established in culture (B) Total RNA isolated from
cells from primary Rgnef+/+ and Rgnef2/2 MEFs and samples
analyzed by RT-PCR using primers to Rgnef and GAPDH.
(TIF)
Video S1 Rgnef+/+ MEF scratch wound motility. Prima-
ry normal (Rgnef+/+) MEFs were plated at a subconfluent density
(75%) on glass bottom dishes (MatTek) coated with FN (1 mg/ml).
After 24 h, cells were serum starved overnight, wounded with a
pipette tip, washed with PBS, and incubated in growth media
containing 0.5 mg/ml of mitomycin-C prior to phase contrast
imaging every 15 min in a humidified 5% CO2 environment at
37uC using an Olympus IX51 microscope, XY-controlled stage
with Z focus drive (Olympus), 106objective (UPLFL, 0.30 NA),
and an OrcaER camera (Hamamatsu) controlled by Slidebook
(v5.0) software. Images were acquired every 15 minutes and
assembled into 10 frames per second video spanning 8 h.
(MOV)
Video S2 Rgnef2/2 MEF scratch wound motility.
Primary Rgnef2/2 MEFs were imaged as described in in the
legend to Video S1.
(MOV)
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